Citations (106)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Giulia Ciotti, Giovanni Marconi, Alessandra Sperotto, Maria B Giannini, Michele Gottardi & Giovanni Martinelli. (2023) Biological therapy in elderly patients with acute myeloid leukemia. Expert Opinion on Biological Therapy 23:2, pages 175-194.
Read now
Read now
Alessia Spagnuolo & Cesare Gridelli. (2019) Combining immunotherapies to treat non-small cell lung cancer. Expert Review of Respiratory Medicine 13:7, pages 621-634.
Read now
Read now
Yayi He, Sangtian Liu, Jane Mattei, Paul A Bunn$suffix/text()$suffix/text(), Caicun Zhou & Daniel Chan. (2018) The combination of anti-KIR monoclonal antibodies with anti-PD-1/PD-L1 monoclonal antibodies could be a critical breakthrough in overcoming tumor immune escape in NSCLC. Drug Design, Development and Therapy 12, pages 981-986.
Read now
Read now
Alexander W. MacFarlane$suffix/text()$suffix/text(), Mowafaq Jillab, Mitchell R. Smith, R. Katherine Alpaugh, Marion E. Cole, Samuel Litwin, Michael M. Millenson, Tahseen Al-Saleem, Adam D. Cohen & Kerry S. Campbell. (2017) NK cell dysfunction in chronic lymphocytic leukemia is associated with loss of the mature cells expressing inhibitory killer cell Ig-like receptors. OncoImmunology 6:7.
Read now
Read now
María V. Martínez-Sánchez, Adela Periago, Isabel Legaz, Lourdes Gimeno, Anna Mrowiec, Natividad R. Montes-Barqueros, José A. Campillo, José M. Bolarin, María V. Bernardo, María R. López-Álvarez, Consuelo González, María C. García-Garay, Manuel Muro, Valentin Cabañas-Perianes, Jose L. Fuster, Ana M. García-Alonso, José M. Moraleda, María R. Álvarez-Lopez & Alfredo Minguela. (2016) Overexpression of KIR inhibitory ligands (HLA-I) determines that immunosurveillance of myeloma depends on diverse and strong NK cell licensing. OncoImmunology 5:4.
Read now
Read now
Krupa Rana & Margaret Whalen. (2015) Activation of protein kinase C and protein kinase D in human natural killer cells: effects of tributyltin, dibutyltin, and tetrabromobisphenol A. Toxicology Mechanisms and Methods 25:9, pages 680-688.
Read now
Read now
Elisabetta Cariani & Gabriele Missale. (2013) KIR/HLA immunogenetic background influences the evolution of hepatocellular carcinoma. OncoImmunology 2:12.
Read now
Read now
Laurent Boissel, Monica Betancur, Weiquan Lu, Daniela Krause, Richard Van Etten, Winfried Wels & Hans Klingemann. (2013) Retargeting NK-92 cells by means of CD19- and CD20-specific chimeric antigen receptors compares favorably with antibody-dependent cellular cytotoxicity. OncoImmunology 2:10.
Read now
Read now
Articles from other publishers (98)
Paul W. Wright, Hongchuan Li, Md Ahasanur Rahman, Erik M. Anderson, Megan Karwan, Jeffrey Carrell & Stephen K. Anderson. (2023) The KIR2DL1 intermediate upstream element participates in gene activation. Immunogenetics 75:6, pages 495-506.
Crossref
Crossref
Reem Ameen, Roshni Titus, Jeethu Anu Geo, Salem Al Shemmari, Daniel E. Geraghty, Chul‐Woo Pyo & Medhat Askar. (2023)
KIR
genotype and haplotype repertoire in Kuwaiti healthy donors, hematopoietic cell transplant recipients and healthy family members
. HLA 102:2, pages 179-191.
Crossref
Crossref
Li Song, Gali Bai, X. Shirley Liu, Bo Li & Heng Li. (2023) Efficient and accurate KIR and HLA genotyping with massively parallel sequencing data. Genome Research 33:6, pages 923-931.
Crossref
Crossref
Cardozo Daniela Maira, Marangon Amanda Vansan, Guimarães Fernando, Marques Silvia, Lieber Sofia, Delamain Márcia, Aranha Francisco José Penteado, Visentainer Jeane Eliete Laguila & de Souza Cármino Antonio. (2023) Association of KIR Genes Polymorphism and its HLA Ligands in Diffuse Large B-cell Lymphoma. Clinical Lymphoma Myeloma and Leukemia 23:6, pages 438-445.
Crossref
Crossref
Jun Huang, Xuedong Chen, Zaoshang Chang, Chuli Xiao & Masoud Najafi. (2023) Boosting Anti-tumour Immunity Using Adjuvant Apigenin. Anti-Cancer Agents in Medicinal Chemistry 23:3, pages 266-277.
Crossref
Crossref
Cinnie Yentia Soekojo & Wee Joo Chng. (2022) The evolution of immune dysfunction in multiple myeloma. European Journal of Haematology 109:5, pages 415-424.
Crossref
Crossref
Galam Leem, Sung-Ill Jang, Jae-Hee Cho, Jung Hyun Jo, Hee Seung Lee, Moon Jae Chung, Jeong Youp Park, Seungmin Bang, Da-Kyung Yoo, Hyo-Cheon Cheon, Jae-Eun Kim, Kyeong-Pill Lim, In-Hye Jung, Jung-Min Im, Yong-Yoon Chung & Seung Woo Park. (2022) Safety and Efficacy of Allogeneic Natural Killer Cells in Combination with Pembrolizumab in Patients with Chemotherapy-Refractory Biliary Tract Cancer: A Multicenter Open-Label Phase 1/2a Trial. Cancers 14:17, pages 4229.
Crossref
Crossref
Nicholas A. Maskalenko, Dmitry Zhigarev & Kerry S. Campbell. (2022) Harnessing natural killer cells for cancer immunotherapy: dispatching the first responders. Nature Reviews Drug Discovery 21:8, pages 559-577.
Crossref
Crossref
Norfarazieda Hassan, Le Jie Lee, Jun Hao Tan, Siti Zuleha Idris, Hishamshah Mohd Ibrahim, Raudhawati Osman, Heng Fong Seow, Norhafizah Mohtaruddin, Andi Anggeriana Andi Asri & Maha Abdullah. (2022) Expression of Killer Cell Immunoglobulin-like Receptors (KIR) in Sex-associated Malignancies. Malaysian Journal of Medicine and Health Sciences 18:4, pages 96-103.
Crossref
Crossref
Hüseyin KAYA, Seda KUŞOĞLU GÜLTEKİN & Belkis ATASEVER ARSLAN. (2022) Doğal Öldürücü Hücre Aktivitesinde İmmunomodulatör Etki Gösteren MoleküllerMolecules That Show Immunomodulator Effect on Natural Killer Cell Activity. Black Sea Journal of Health Science 5:2, pages 312-317.
Crossref
Crossref
Sandro Matosevic. 2022. Systemic Drug Delivery Strategies. Systemic Drug Delivery Strategies
63
82
.
Uwe Fischer & Fumio Takizawa. 2022. Principles of Fish Immunology. Principles of Fish Immunology
141
176
.
Hwa-Youn Lee, Eun-Hee Lee, Jawoon Yi, Kon-Young Ji, Su-Man Kim, Ha-Rim Choi, Su-Min Yee, Hyung-Sik Kang & Eun-Mi Kim. (2021) TREM2 promotes natural killer cell development in CD3−CD122+NK1.1+ pNK cells. BMC Immunology 22:1.
Crossref
Crossref
Ana Vuletić, Katarina Mirjačić Martinović, Nevena Tišma Miletić, Jerome Zoidakis, Sergi Castellvi-Bel & Milena Čavić. (2021) Cross-Talk Between Tumor Cells Undergoing Epithelial to Mesenchymal Transition and Natural Killer Cells in Tumor Microenvironment in Colorectal Cancer. Frontiers in Cell and Developmental Biology 9.
Crossref
Crossref
Thaise Gonçalves Araújo, Sara Teixeira Soares Mota, Helen Soares Valença Ferreira, Matheus Alves Ribeiro, Luiz Ricardo Goulart & Lara Vecchi. (2021) Annexin A1 as a Regulator of Immune Response in Cancer. Cells 10:9, pages 2245.
Crossref
Crossref
Giorgio Santoni, Consuelo Amantini, Matteo Santoni, Federica Maggi, Maria Beatrice Morelli & Angela Santoni. (2021) Mechanosensation and Mechanotransduction in Natural Killer Cells. Frontiers in Immunology 12.
Crossref
Crossref
Esti Toledo, Guillaume Le Saux, Avishay Edri, Long LiMaor Rosenberg, Yossi KeidarViraj Bhingardive, Olga RadinskyUzi Hadad, Carmelo Di Primo, Thierry BuffeteauAna-Sunčana SmithAngel Porgador & Mark Schvartzman. (2021) Molecular-scale spatio-chemical control of the activating-inhibitory signal integration in NK cells. Science Advances 7:24, pages eabc1640.
Crossref
Crossref
Emiliana Weiss, Heloisa S. Andrade, Juliana Rodrigues Lara, Andreia S. Souza, Michelle A. Paz, Thálitta H. A. Lima, Iane O. P. Porto, Nayane S. B. Silva, Camila F. Bannwart Castro, Rejane M. T. Grotto, Eduardo A. Donadi, Celso T. Mendes-Junior & Erick C. Castelli. (2021) KIR2DL4 genetic diversity in a Brazilian population sample: implications for transcription regulation and protein diversity in samples with different ancestry backgrounds. Immunogenetics 73:3, pages 227-241.
Crossref
Crossref
Clifford M. Csizmar & Stephen M. Ansell. (2021) Engaging the Innate and Adaptive Antitumor Immune Response in Lymphoma. International Journal of Molecular Sciences 22:7, pages 3302.
Crossref
Crossref
Philippe Armand, Alexander Lesokhin, Ivan Borrello, John Timmerman, Martin Gutierrez, Lili Zhu, Mihaela Popa McKiver & Stephen M. Ansell. (2020) A phase 1b study of dual PD-1 and CTLA-4 or KIR blockade in patients with relapsed/refractory lymphoid malignancies. Leukemia 35:3, pages 777-786.
Crossref
Crossref
Hao Liu, Zi-Ying Wang, Yu-Cong Zhou, Wei Song, Usman Ali & Daniel M.-Y Sze. (2021) Immunomodulation of Chinese Herbal Medicines on NK cell populations for cancer therapy: A systematic review. Journal of Ethnopharmacology 268, pages 113561.
Crossref
Crossref
Raquel Lopes, Joana Caetano, Bruna Ferreira, Filipa Barahona, Emilie Arnault Carneiro & Cristina João. (2021) The Immune Microenvironment in Multiple Myeloma: Friend or Foe?. Cancers 13:4, pages 625.
Crossref
Crossref
Kyle Lupo & Sandro Matosevic. 2021. Successes and Challenges of NK Immunotherapy. Successes and Challenges of NK Immunotherapy
349
368
.
Sicong Huang, Zijun Song, Tiesong Zhang, Xuyan He, Kaiyuan Huang, Qihui Zhang, Jian Shen & Jianwei Pan. (2020) Identification of Immune Cell Infiltration and Immune-Related Genes in the Tumor Microenvironment of Glioblastomas. Frontiers in Immunology 11.
Crossref
Crossref
Sachin Kumar Singh Chauhan, Ulrike Koehl & Stephan Kloess. (2020) Harnessing NK Cell Checkpoint-Modulating Immunotherapies. Cancers 12:7, pages 1807.
Crossref
Crossref
Muhammad Khan, Sumbal Arooj & Hua Wang. (2020) NK Cell-Based Immune Checkpoint Inhibition. Frontiers in Immunology 11.
Crossref
Crossref
Shaghik Barani, Bijan Khademi & Abbas Ghaderi. (2020) KIR2DS4, KIR2DL2, and KIR2DS4del are linked with basaloid tumors, lymph node metastasis, advanced stage and metastatic risk in head and neck squamous cell carcinoma. Experimental and Molecular Pathology 112, pages 104345.
Crossref
Crossref
Begum Dariya & Ganji Purnachandra Nagaraju. 2020. Immunotherapy for Gastrointestinal Malignancies. Immunotherapy for Gastrointestinal Malignancies
205
230
.
Vladimir Jurišić, Ana Vuletić, Katarina Mirjačić Martinović & Gordana Konjević. 2020. Cancer Immunology. Cancer Immunology
133
146
.
Suwit Chaisri & Chanvit Leelayuwat. 2019. Cancer Immunotherapy and Biological Cancer Treatments. Cancer Immunotherapy and Biological Cancer Treatments.
Yang Li, Bingnan Liu, Shaoxue Ding, Chunyan Liu, Tong Chen, Lijuan Li, Zonghong Shao & Rong Fu. (2019) Availability of NK cell expansion agent combined with recombinant IL‑2 and IL‑15 stimulation on the expansion and high‑purity of NK cells in patients with immune‑related pancytopenia in�vitro. Molecular Medicine Reports.
Crossref
Crossref
Opeyemi S. Soremekun & Mahmoud E.S. Soliman. (2019) From genomic variation to protein aberration: Mutational analysis of single nucleotide polymorphism present in ULBP6 gene and implication in immune response. Computers in Biology and Medicine 111, pages 103354.
Crossref
Crossref
Vasyl Eisenberg, Shiran Hoogi, Astar Shamul, Tilda Barliya & Cyrille J. Cohen. (2019) T-cells “à la CAR-T(e)” – Genetically engineering T-cell response against cancer. Advanced Drug Delivery Reviews 141, pages 23-40.
Crossref
Crossref
Kerry S. Campbell, Adam D. Cohen & Tatiana Pazina. (2018) Mechanisms of NK Cell Activation and Clinical Activity of the Therapeutic SLAMF7 Antibody, Elotuzumab in Multiple Myeloma. Frontiers in Immunology 9.
Crossref
Crossref
Alessandra Gentilini, Mirella Pastore, Fabio Marra & Chiara Raggi. (2018) The Role of Stroma in Cholangiocarcinoma: The Intriguing Interplay between Fibroblastic Component, Immune Cell Subsets and Tumor Epithelium. International Journal of Molecular Sciences 19:10, pages 2885.
Crossref
Crossref
Jesse Bruijnesteijn, Marit K. H. van der Wiel, Wendy T. N. Swelsen, Nel Otting, Annemiek J. M. de Vos-Rouweler, Diënne Elferink, Gaby G. Doxiadis, Frans H. J. Claas, Neubury M. Lardy, Natasja G. de Groot & Ronald E. Bontrop. (2018)
Human and Rhesus Macaque
KIR
Haplotypes Defined by Their Transcriptomes
. The Journal of Immunology 200:5, pages 1692-1701.
Crossref
Crossref
Minoru Koi, Yoshiki Okita & John M. Carethers. (2018) <i>Fusobacterium nucleatum</i> Infection in Colorectal Cancer: Linking Inflammation, DNA Mismatch Repair and Genetic and Epigenetic Alterations. Journal of the Anus, Rectum and Colon 2:2, pages 37-46.
Crossref
Crossref
Nicolas Villanueva & Lyudmila Bazhenova. (2018) New strategies in immunotherapy for lung cancer: beyond PD-1/PD-L1. Therapeutic Advances in Respiratory Disease 12, pages 175346661879413.
Crossref
Crossref
Tanner M. Johanns & Gavin P. Dunn. 2018. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy
653
668
.
Jennifer Moy & Robert L. Ferris. 2018. Molecular Determinants of Head and Neck Cancer. Molecular Determinants of Head and Neck Cancer
365
396
.
Lynda Addou-Klouche. 2017. Natural Killer Cells. Natural Killer Cells.
Gordana Konjević, Ana Vuletić, Katarina Mirjačić Martinović & Radan Džodić. 2017. Natural Killer Cells. Natural Killer Cells.
Vasyl Eisenberg, Katerina Shamalov, Shimrit Meir, Shiran Hoogi, Rhitajit Sarkar, Shirel Pinker, Gal Markel, Angel Porgador & Cyrille J. Cohen. (2017) Targeting Multiple Tumors Using T-Cells Engineered to Express a Natural Cytotoxicity Receptor 2-Based Chimeric Receptor. Frontiers in Immunology 8.
Crossref
Crossref
Minoru Koi & John M Carethers. (2017) The colorectal cancer immune microenvironment and approach to immunotherapies. Future Oncology 13:18, pages 1633-1647.
Crossref
Crossref
Maria Giovanna Dal Bello, Angela Alama, Simona Coco, Irene Vanni & Francesco Grossi. (2017) Understanding the checkpoint blockade in lung cancer immunotherapy. Drug Discovery Today 22:8, pages 1266-1273.
Crossref
Crossref
Zachary B. Davis, Daniel A. Vallera, Jeffrey S. Miller & Martin Felices. (2017) Natural killer cells unleashed: Checkpoint receptor blockade and BiKE/TriKE utilization in NK-mediated anti-tumor immunotherapy. Seminars in Immunology 31, pages 64-75.
Crossref
Crossref
Jennifer D. Moy, Jessica M. Moskovitz & Robert L. Ferris. (2017) Biological mechanisms of immune escape and implications for immunotherapy in head and neck squamous cell carcinoma. European Journal of Cancer 76, pages 152-166.
Crossref
Crossref
Pâmela Portela, Joice Merzoni, Juliana D. Lindenau, Daniel C. Damin, Timothy John Wilson, Rafael Roesler, Gilberto Schwartsmann, Luiz Fernando Jobim & Mariana Jobim. (2017) KIR genes and HLA class I ligands in a Caucasian Brazilian population with colorectal cancer. Human Immunology 78:3, pages 263-268.
Crossref
Crossref
Yonat Shemer-Avni, Kiran Kundu, Avishai Shemesh, Michael Brusilovsky, Rami Yossef, Mesfin Meshesha, Semaria Solomon-Alemayehu, Shai Levin, Orly Gershoni-Yahalom, Kerry S. Campbell & Angel Porgador. (2017) Expression of NKp46 Splice Variants in Nasal Lavage Following Respiratory Viral Infection: Domain 1-Negative Isoforms Predominate and Manifest Higher Activity. Frontiers in Immunology 8.
Crossref
Crossref
Zachary B. DavisBharatwaj SowrirajanAndrew CogswellJeffery P. WardVicente PlanellesEdward Barker. (2017) CD155 on HIV-Infected Cells Is Not Modulated by HIV-1 Vpu and Nef but Synergizes with NKG2D Ligands to Trigger NK Cell Lysis of Autologous Primary HIV-Infected Cells. AIDS Research and Human Retroviruses 33:2, pages 93-100.
Crossref
Crossref
Hui Yu, Fang Liu, Benoit Sansas, Bin Kang, Xavier Preville, Xianghua Wu, Jianhua Chang, Romain Micol, Jialei Wang & Xia Meng. (2016) Typing of killer-cell immunoglobulin-like receptors and their cognate human leukocyte antigen class I ligands predicts survival of Chinese Han patients with metastatic non-small-cell lung cancer. Molecular and Clinical Oncology.
Crossref
Crossref
Don M. BensonJrJr. (2016) Checkpoint inhibition in myeloma. Hematology 2016:1, pages 528-533.
Crossref
Crossref
Ozgur Kartal, Ugur Musabak, Sait Yesillik, Rahsan I. Sagkan, Aysel Pekel, Fevzi Demirel, Abdullah Baysan, Ali Selçuk, Mustafa Güleç & Osman Şener. (2015) Killer-cell immunoglobulin-like receptor and human leukocyte antigen-C genes in common variable immunodeficiency. Wiener klinische Wochenschrift 128:21-22, pages 822-826.
Crossref
Crossref
Taco W. Kuijpers, Sanne Vendelbosch, Merlijn van den Berg & Dominique L.P. Baeten. (2016) Killer immunoglobulin receptor genes in spondyloarthritis. Current Opinion in Rheumatology 28:4, pages 368-375.
Crossref
Crossref
Han Chen, Wang Zhidan, Ren Xia, Wang Zhaoxia, Jia Qing, Guo Qiang, Yin Haipeng & Wang Hengxiao. (2016) Scorpion venom activates natural killer cells in hepatocellular carcinoma via the NKG2D-MICA pathway. International Immunopharmacology 35, pages 307-314.
Crossref
Crossref
Can Küçük, Xiaozhou Hu, Qiang Gong, Bei Jiang, Adam Cornish, Philippe Gaulard, Timothy McKeithan & Wing C. Chan. (2016) Diagnostic and Biological Significance of KIR Expression Profile Determined by RNA-Seq in Natural Killer/T-Cell Lymphoma. The American Journal of Pathology 186:6, pages 1435-1441.
Crossref
Crossref
Karin A. Vineretsky, Margaret R. Karagas, Brock C. Christensen, Jacquelyn K. Kuriger-Laber, Ann E. Perry, Craig A. Storm & Heather H. Nelson. (2016) Skin Cancer Risk Is Modified by KIR/HLA Interactions That Influence the Activation of Natural Killer Immune Cells. Cancer Research 76:2, pages 370-376.
Crossref
Crossref
David T. Yeung, Carine Tang, Ljiljana VidovicDeborah L. WhiteSusan Branford, Timothy P. HughesAgnes S. Yong. (2015) KIR2DL5B genotype predicts outcomes in CML patients treated with response-directed sequential imatinib/nilotinib strategy. Blood 126:25, pages 2720-2723.
Crossref
Crossref
Giovanni Caocci, Bruno Martino, Marianna Greco, Elisabetta Abruzzese, Malgorzata Monika Trawinska, Sara Lai, Paola Ragatzu, Sara Galimberti, Claudia Baratè, Olga Mulas, Claudia Labate, Roberto Littera, Carlo Carcassi, Carlo Gambacorti Passerini & Giorgio La Nasa. (2015) Killer immunoglobulin-like receptors can predict TKI treatment-free remission in chronic myeloid leukemia patients. Experimental Hematology 43:12, pages 1015-1018.e1.
Crossref
Crossref
Suliman Y. Al OmarLamjed MansourJavid Ahmed DarSaleh AlwaselAfrah AlkhurijiMaha ArafahOmar Al ObeedStephen Christmas. (2015) The Relationship Between Killer Cell Immunoglobulin-Like Receptors and HLA-C Polymorphisms in Colorectal Cancer in a Saudi Population. Genetic Testing and Molecular Biomarkers 19:11, pages 617-622.
Crossref
Crossref
Steven N Seyedin, Jonathan E Schoenhals, Dean A Lee, Maria A Cortez, Xiaohong Wang, Sharareh Niknam, Chad Tang, David S Hong, Aung Naing, Padmanee Sharma, James P Allison, Joe Y Chang, Daniel R Gomez, John V Heymach, Ritsuko U Komaki, Laurence J Cooper & James W Welsh. (2015) Strategies for combining immunotherapy with radiation for anticancer therapy. Immunotherapy 7:9, pages 967-980.
Crossref
Crossref
Gregory K. PennockLaura Q.M. Chow. (2015) The Evolving Role of Immune Checkpoint Inhibitors in Cancer Treatment. The Oncologist 20:7, pages 812-822.
Crossref
Crossref
Stalinraja Maruthamuthu & Jayalakshmi Mariakuttikan. (2015) Predominance of B haplotype associated KIR genes in Tamil Speaking Dravidians. Human Immunology 76:5, pages 344-347.
Crossref
Crossref
Michael Brusilovsky, Olga Radinsky, Limor Cohen, Rami Yossef, Avishai Shemesh, Alex Braiman, Ofer Mandelboim, Kerry S. Campbell & Angel Porgador. (2015)
Regulation of natural cytotoxicity receptors by heparan sulfate proteoglycans in
‐cis
: A lesson from NKp44
. European Journal of Immunology 45:4, pages 1180-1191.
Crossref
Crossref
R. E. Gardiner, S. Jahangeer, P. Forde, A. B. Ariffin, B. Bird, D. Soden & J. Hinchion. (2015) Low immunogenicity in non-small cell lung cancer; do new developments and novel treatments have a role?. Cancer and Metastasis Reviews 34:1, pages 129-144.
Crossref
Crossref
Lakshmi Narendra Bodduluru, Eshvendar Reddy Kasala, Rajaram Mohan Rao Madhana & Chandra Shaker Sriram. (2015) Natural killer cells: The journey from puzzles in biology to treatment of cancer. Cancer Letters 357:2, pages 454-467.
Crossref
Crossref
Shigeru Tsuboi. 2015. Sugar Chains. Sugar Chains
177
188
.
Giuseppe V. Masucci, Luigi De Petris, Andreas Lundqvist, Rolf Kiessling & Rolf Lewensohn. 2015. Developments in T Cell Based Cancer Immunotherapies. Developments in T Cell Based Cancer Immunotherapies
211
229
.
Gregor Reid. 2015. Genomic Instability and Cancer Metastasis. Genomic Instability and Cancer Metastasis
159
177
.
Scott J. Antonia, James Larkin & Paolo A. Ascierto. (2014) Immuno-oncology Combinations: A Review of Clinical Experience and Future Prospects. Clinical Cancer Research 20:24, pages 6258-6268.
Crossref
Crossref
Sara Chiappalupi, Francesca Riuzzi, Stefania Fulle, Rosario Donato & Guglielmo Sorci. (2014) Defective RAGE activity in embryonal rhabdomyosarcoma cells results in high PAX7 levels that sustain migration and invasiveness. Carcinogenesis 35:10, pages 2382-2392.
Crossref
Crossref
Hyung-Jin Kim, Hae-Baeg Choi, Jung-Pil Jang, In-Cheol Baek, Eun-Jeong Choi, Miyoung Park, Tai-Gyu Kim & Seong-Taek Oh. (2014) HLA-Cw polypmorphism and killer cell immunoglobulin-like receptor (KIR) gene analysis in Korean colorectal cancer patients. International Journal of Surgery 12:8, pages 815-820.
Crossref
Crossref
Anupam Dutta, Nabajyoti Saikia, Jyotirmoy Phookan, Munindra Narayan Baruah & Shashi Baruah. (2014) Association of killer cell immunoglobulin-like receptor gene 2DL1 and its HLA-C2 ligand with family history of cancer in oral squamous cell carcinoma. Immunogenetics 66:7-8, pages 439-448.
Crossref
Crossref
Nadia Anikeeva, Maria Steblyanko, Svetlana Fayngerts, Natalya Kopylova, Deborah J. Marshall, Gordon D. Powers, Takami Sato, Kerry S. Campbell & Yuri Sykulev. (2014) Integrin receptors on tumor cells facilitate NK cell-mediated antibody-dependent cytotoxicity. European Journal of Immunology 44:8, pages 2331-2339.
Crossref
Crossref
Sasijit Vejbaesya, Pradermchai Sae-Tam, Archrob Khuhapinant & Duangporn Srinak. (2014) Killer cell immunoglobulin-like receptors in Thai patients with leukemia and diffuse large B-cell lymphoma. Human Immunology 75:7, pages 673-676.
Crossref
Crossref
Don M. BensonJrJr & Michael A. Caligiuri. (2014) Killer Immunoglobulin-like Receptors and Tumor Immunity. Cancer Immunology Research 2:2, pages 99-104.
Crossref
Crossref
Justyna Kmiecik, Jacques Zimmer & Martha Chekenya. (2013) Natural killer cells in intracranial neoplasms: presence and therapeutic efficacy against brain tumours. Journal of Neuro-Oncology 116:1, pages 1-9.
Crossref
Crossref
Irene Maeve Rea, Lynn D Maxwell, Susan E McNerlan, H Denis Alexander, Martin D Curran, Derek Middleton & Owen A Ross. (2013) Killer Immunoglobulin-like Receptors (KIR) haplogroups A and B track with Natural Killer Cells and Cytokine Profile in Aged Subjects: Observations from Octo/Nonagenarians in the Belfast Elderly Longitudinal Free-living Aging STudy (BELFAST). Immunity & Ageing 10:1.
Crossref
Crossref
Michael Brusilovsky, Moti Cordoba, Benyamin Rosental, Oren Hershkovitz, Mark D. Andrake, Anna Pecherskaya, Margret B. Einarson, Yan Zhou, Alex Braiman, Kerry S. Campbell & Angel Porgador. (2013) Genome-Wide siRNA Screen Reveals a New Cellular Partner of NK Cell Receptor KIR2DL4: Heparan Sulfate Directly Modulates KIR2DL4-Mediated Responses. The Journal of Immunology 191:10, pages 5256-5267.
Crossref
Crossref
Justyna Kmiecik, Aurélie Poli, Nicolaas H.C. Brons, Andreas Waha, Geir Egil Eide, Per Øyvind Enger, Jacques Zimmer & Martha Chekenya. (2013) Elevated CD3+ and CD8+ tumor-infiltrating immune cells correlate with prolonged survival in glioblastoma patients despite integrated immunosuppressive mechanisms in the tumor microenvironment and at the systemic level. Journal of Neuroimmunology 264:1-2, pages 71-83.
Crossref
Crossref
Gurman Kaur, John Trowsdale & Lars Fugger. (2013) Natural killer cells and their receptors in multiple sclerosis. Brain 136:9, pages 2657-2676.
Crossref
Crossref
Maria Regina Jobim, Mariana Jobim, Patrícia H. Salim, Pâmela Portela, Luiz Fernando Jobim, Sandra Leistner-Segal, Ana Cristina Bittelbrunn, Carlos Henrique Menke, Jorge Villanova Biazús, Rafael Roesler & Gilberto Schwartsmann. (2013) Analysis of KIR gene frequencies and HLA class I genotypes in breast cancer and control group. Human Immunology 74:9, pages 1130-1133.
Crossref
Crossref
Kelsi Hurt, Tasia Hurd‐Brown & Margaret Whalen. (2012) Tributyltin and dibutyltin alter secretion of tumor necrosis factor alpha from human natural killer cells and a mixture of T cells and natural killer cells. Journal of Applied Toxicology 33:6, pages 503-510.
Crossref
Crossref
Tasia Hurd‐Brown, Felicia Udoji, Tamara Martin & Margaret M. Whalen. (2012) Effects of DDT and triclosan on tumor‐cell binding capacity and cell‐surface protein expression of human natural killer cells. Journal of Applied Toxicology 33:6, pages 495-502.
Crossref
Crossref
Min Cheng, Yongyan Chen, Weihua Xiao, Rui Sun & Zhigang Tian. (2013) NK cell-based immunotherapy for malignant diseases. Cellular & Molecular Immunology 10:3, pages 230-252.
Crossref
Crossref
Giorgio La Nasa, Giovanni Caocci, Roberto Littera, Sandra Atzeni, Adriana Vacca, Olga Mulas, Marzia Langiu, Marianna Greco, Sandro Orrù, Nicola Orrù, Andrea Floris & Carlo Carcassi. (2013) Homozygosity for killer immunoglobin-like receptor haplotype A predicts complete molecular response to treatment with tyrosine kinase inhibitors in chronic myeloid leukemia patients. Experimental Hematology 41:5, pages 424-431.
Crossref
Crossref
Scott A. Koepsell, Jeffrey S. Miller & David H. McKenna Jr. (2013) Natural killer cells: a review of manufacturing and clinical utility. Transfusion 53:2, pages 404-410.
Crossref
Crossref
Dmitriy W. Gutkin. 2013. The Tumor Immunoenvironment. The Tumor Immunoenvironment
39
82
.
Jessica F. Brinkworth & Mitchell Thorn. 2013. Primates, Pathogens, and Evolution. Primates, Pathogens, and Evolution
17
64
.
Andrzej Wiśniewski, Renata Jankowska, Ewa Passowicz-Muszyńska, Elżbieta Wiśniewska, Edyta Majorczyk, Izabela Nowak, Irena Frydecka & Piotr Kuśnierczyk. (2012) KIR2DL2/S2 and HLA-C C1C1 genotype is associated with better response to treatment and prolonged survival of patients with non-small cell lung cancer in a Polish Caucasian population. Human Immunology 73:9, pages 927-931.
Crossref
Crossref
Katarina Mirjačić Martinović, Gordana Konjević, Nada Babović & Momčilo Inić. (2011) The Stage Dependent Changes in NK Cell Activity and the Expression of Activating and Inhibitory NK Cell Receptors in Melanoma Patients. Journal of Surgical Research 171:2, pages 637-649.
Crossref
Crossref
Juan A. García-León, María J. Pinto-Medel, Lucía García-Trujillo, Carlos López-Gómez, Begoña Oliver-Martos, Isidro Prat-Arrojo, Carmen Marín-Bañasco, Margarita Suardíaz-García, Rafael Maldonado-Sanchez, Óscar Fernández-Fernández & Laura Leyva-Fernández. (2011) Killer cell immunoglobulin-like receptor genes in Spanish multiple sclerosis patients. Molecular Immunology 48:15-16, pages 1896-1902.
Crossref
Crossref
Yori Gidron, Bibiana Fabre, Halina Grosman, Carlos Nolazco, Viviana Mesch, Osvaldo Mazza & Gabriela Berg. (2011) Life events, cortisol and levels of prostate specific antigen: A story of synergism. Psychoneuroendocrinology 36:6, pages 874-880.
Crossref
Crossref
Kerry S. Campbell & Amanda K. Purdy. (2011) Structure/function of human killer cell immunoglobulin-like receptors: lessons from polymorphisms, evolution, crystal structures and mutations. Immunology 132:3, pages 315-325.
Crossref
Crossref
R Rosenquist & A Porwit. 2011. Blood and Bone Marrow Pathology. Blood and Bone Marrow Pathology
407
418
.
Rupert Handgretinger. (2010) Donor selection for AML: do the KIR. Blood 116:14, pages 2407-2409.
Crossref
Crossref
Anastazia M. Older Aguilar, Lisbeth A. Guethlein, Erin J. Adams, Laurent Abi-Rached, Achim K. Moesta & Peter Parham. (2010) Coevolution of Killer Cell Ig-Like Receptors with HLA-C To Become the Major Variable Regulators of Human NK Cells. The Journal of Immunology 185:7, pages 4238-4251.
Crossref
Crossref
John W. OllerJr.Jr.. (2010) The Antithesis of Entropy: Biosemiotic Communication from Genetics to Human Language with Special Emphasis on the Immune Systems. Entropy 12:4, pages 631-705.
Crossref
Crossref